Mumbai: Contact lens major, Bausch & Lomb has entered into India’s booming aesthetic market with launch of leading U.S. brands like ‘Thermage’ & ‘Fraxel’. The move comes in to address the burgeoning $230 million Aesthetics market. According to rough industry data, India performs 1.1 million cosmetic procedures every year.

Bausch & Lomb intends to cater to India’s HNI’s (high net worth individual) segment who are looking & demanding for world-class aesthetic treatments. It will come up with wide range of invasive & non-invasive aesthetic treatments into the anti-ageing, skin tightening, body-contouring and skin enhancement segment. Brands like Thermage, Fraxel and Clear+Brilliant being launched now. Other brands like Liposonix, Vaserlipo, Vasershape and Isolaz will be launched at market appropriate time.

These brands are targeted at top Indian cosmetologists including dermatologists and leading chains of skin care clinics who will further offer the treatment to end-consumer. Currently in India, such  aesthetic procedures from a leading cosmetologist in metros, may cost anywhere between $300-$1300 per treatment.

The company intends to achieve a 10% market share in next 2-3 years, especially in the non-invasive segment, said Mr. Sanjay Bhutani, Managing Director, India & SAARC at Bausch & Lomb India.

Talking about the Vision for Bausch & Lomb aesthetics business, Mr. Bhutani said, “With over 7,000 customers worldwide who have been using our brands, our products have already been used for over 2 million treatments across 100 countries. Our devices are a combination of science, substance & style. Now, beauty conscious Indian consumers will also have access to best-in-class aesthetic treatment.”

Bausch & Lomb India owns more than 60 % market share in lens category and around 90% market share in lens care category, also offers the most comprehensive portfolio in IOL’s, Phaco machines and other eye health products.